#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adrenogenital syndrome Hodgkin's disease Blood iron increased Neurodevelopmental disorder Ventricular tachycardia Anaplastic large cell lymphoma T- and null-cell types Usher's syndrome Ewing's sarcoma Paraneoplastic neurological syndrome Urea cycle disorder Oesophageal atresia Rhabdomyosarcoma Transferrin decreased Oropharyngeal squamous cell carcinoma Ocular lymphoma More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Diagnostics Antisynthetase syndrome Niemann-Pick disease – Basic Information Basal cell naevus syndrome – Treatment Sarcoma – Treatment Ewing’s sarcoma metastatic – Life with Disease Lennox-Gastaut syndrome – Treatment Nodal marginal zone B-cell lymphoma – Treatment Krabbe’s disease – Diagnostics Mantle cell lymphoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Omeprazole Tin816 Tolcapone Mva-209-Fsp-B2 Altizide Varenicline Norfloxacin GVV858 Zelicapavir AVTX-009 Cariprazine Hydrochloride Cobimetinib Dronedarone Axicabtagene Ciloleucel FERUMOXTRAN-10 Rimegepant Linaclotide Lacutamab Remestemcel Venlafaxine More therapies…

    Learn about Your Condition

    Angelman's syndrome Mucopolysaccharidosis II Lymphangiosarcoma Sinus rhythm Knee arthroplasty Psychotic behaviour Morning sickness Vulvovaginal pruritus Plasmablastic lymphoma Acromegaly Dementia Alzheimer's type Latent tuberculosis Benign prostatic hyperplasia Stress urinary incontinence Hidradenitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Medullary thyroid cancer

  • A study of EP0031 and drug combination for patients with advanced cancers having changes in the RET gene

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Medullary thyroid cancer
    • Neoplasm malignant
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Ep0031
    • Carboplatin
    • Cisplatin
    France Germany Italy Poland Spain

  • Comparison of two doses of cabozantinib (60 mg vs 140 mg) in patients with progressive metastatic medullary thyroid cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Medullary thyroid cancer
    Investigated Drugs:
    • Cabozantinib
    Croatia Hungary Poland Romania

  • Study on the Effects of Selpercatinib in Patients Aged 12 and Older with Advanced Solid Tumors with RET Gene Alteration

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Medullary thyroid cancer
    • Neoplasm
    • Non-small cell lung cancer
    Investigated Drugs:
    • Selpercatinib
    Denmark France Germany Italy Spain

  • Study on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Selpercatinib
    Denmark France Germany Italy Spain

  • Study on Selpercatinib for Adults with Advanced or Metastatic Solid Tumors with RET Activation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    • Medullary thyroid cancer
    • Papillary thyroid cancer
    Investigated Drugs:
    • Selpercatinib
    France Italy Poland Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!